4-Methyl-1,2,5-oxadiazole-3-carboxylic acid

Catalog No.: 
ACUSPQ813
CAS No.: 
58677-34-2
Molecular Formula: 
C4H4N2O3
Molecular Weight: 
128.09
4-Methyl-1,2,5-oxadiazole-3-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$56.00In stockInquiry
5g98%$274.00In stockIn stock
10g98%$509.00In stockIn stock
25g98%$1109.00In stockInquiry
100g98%$3548.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Methyl-1,2,5-oxadiazole-3-carboxylic acid
IUPAC Name4-methyl-1,2,5-oxadiazole-3-carboxylic acid
MDL No.MFCD00461519
Molecular FormulaC4H4N2O3
Molecular Weight128.09
SMILESCC1=NON=C1C(O)=O
InChI KeyGAIAHHRZVGJYQW-UHFFFAOYSA-N
SynonymEN300-75674 | FT-0677184 | SCHEMBL261709 | 1,2,5-oxadiazole-3-carboxylic acid, 4-methyl- | DTXSID00310934 | NSC234497 | NSC-234497 | 4-methyl-1,2,5-oxadiazole-3-carboxylicacid | 4-methyl-1,2,5-oxadiazole-3-carboxylic acid | CS-0099433 | SY079200 | S12290
CAS No.58677-34-2
PubChem CID314768

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACUSPQ813 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACUSPQ813 route product structure diagram
    ACUSPQ81358677-34-2In Stock
Inquiry

2. ACUSPQ813 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACUSPQ813 route product structure diagram
    ACUSPQ81358677-34-2In Stock
Inquiry

3. ACUSPQ813 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACUSPQ813 route product structure diagram
    ACUSPQ81358677-34-2In Stock
Inquiry

Comments (0)